EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


First published online July 18, 2008
Experimental Biology and Medicine 233:1222-1230 (2008)
doi: 10.3181/0802-RM-73
© 2008 by the Society for Experimental Biology and Medicine

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
233/10/1222    most recent
0802-RM-73v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Caretti, A.
Right arrow Articles by Samaja, M.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Caretti, A.
Right arrow Articles by Samaja, M.


ORIGINAL RESEARCH ARTICLE

Phosphodiesterase-5 Inhibition Abolishes Neuron Apoptosis Induced by Chronic Hypoxia Independently of Hypoxia-Inducible Factor-1{alpha} Signaling

Anna Caretti*,{dagger}, Paola Bianciardi*, Raffaella Ronchi*, Monica Fantacci*, Marco Guazzi* and Michele Samaja*,1

* Department of Medicine, Surgery and Dentistry, University of Milan, San Paolo Hospital, Milan, Italy; and {dagger} Istituto Nazionale per le Ricerche Cardiovascolari, Bologna, Italy

To whom requests for reprints should be addressed at 1 University of Milan, San Paolo Hospital, via di Rudinì 8 I-20142 Milan, Italy. E-mail: michele.samaja{at}unimi.it and michelesamaja{at}yahoo.it.

Exposure to hypoxia triggers a variety of adverse effects in the brain that arise from metabolic stress and induce neuron apoptosis. Overexpression of the hypoxia-inducible factor-1{alpha} (HIF-1{alpha}) is believed to be a major candidate in orchestrating the cell’s defense against stress. To test the impact of HIF-1{alpha} on apoptosis during chronic hypoxia in vivo, we examined the protective effect of modulating the nitric oxide (NO)/cGMP pathway by sildenafil, a selective inhibitor of phosphodiesterase-5 (PDE-5). Male ICR/CD-1 mice were divided into 3 groups (n = 6/group): normoxic (21% O2), hypoxic (9.5% O2), and hypoxic with sildenafil (1.4-mg/kg intraperitoneal injections daily). At the end of the 8-day treatment period, the mice were euthanized and cerebral cortex biopsies were harvested for analyses. We found that sildenafil: (1) did not significantly alter the hypoxia-induced weight loss and hemoglobin increase, but did augment plasma nitrates+nitrites and the tissue content of cGMP and phosphorylated (P) NO synthase III; (2) reversed the hypoxia-induced neuron apoptosis (terminal deoxynucleotidyl transferase positivity and double-staining immunofluorescence, P = 0.009), presumably through increased bcl-2/Bax (P = 0.0005); and (3) did not affect HIF-1{alpha}, but rather blunted the hypoxia-induced increase in P-ERK1/2 (P = 0.0002) and P-p38 (P = 0.004). We conclude that upregulating the NO/cGMP pathway by PDE-5 inhibition during hypoxia reduces neuron apoptosis, regardless of HIF-1{alpha}, through an interaction involving ERK1/2 and p38.

Key Words: chronic hypoxia • hypoxia signaling • HIF-1{alpha} • NO • bcl-2







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by the Society for Experimental Biology and Medicine.